A cross-sectional cohort study of 979 pediatric SLE patients from CARRA registry showed an overall prevalence of arterial and venous thrombosis (independently of aPL status) of 2.5% and 3.6%, and the detection of any aPL significantly increased the overall thrombosis risk [54]. The gene discussed is FASLG; the disease is Venous thrombosis.